This study is the first to directly investigate the impact of a two‐week tsDCS protocol applied to SOD1 mice at a presymptomatic stage of ALS on the electrophysiological and biochemical properties of MNs. This evidence concerns the gene SOD1 and amyotrophic lateral sclerosis.